GHO Capital, a specialist healthcare investment company, agreed to buy Sterling Pharma Solutions, an active pharmaceutical ingredient manufacturer. Financial terms were not disclosed. “We are delighted to partner with GHO Capital, whose expertise in the pharmaceuticals space and track record of supporting companies expand internationally will be invaluable in facilitating the next stage of our growth in Europe and in the US.” Kevin Cook, Sterling Pharma Solutions CEO.